Ann Madsen

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

Philip J. Mease, Christina Charles‐Schoeman, Stanley Cohen et al. · Annals of the Rheumatic Diseases · 2020 · 214 citations · Full text

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

Stanley Cohen, Yoshiya Tanaka, Xavier Mariette et al. · RMD Open · 2020 · 170 citations · Full text

Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed.

P. Krogh, N H Axelsen, Folmer Elling et al. · PubMed · 1974 · 142 citations

Animal Physiology, Glomerulonephritis, Renal Function +14

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry

Joel M. Kremer, Clifton O. Bingham, Laura C. Cappelli et al. · ACR Open Rheumatology · 2021 · 135 citations · Full text

Antioxidant Vitamin Supplementation Reduces Benzo(<i>a</i>)pyrene-DNA Adducts and Potential Cancer Risk in Female Smokers

LaVerne A. Mooney, Ann Madsen, Deliang Tang et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 80 citations